The U.S. Supreme Court on Tuesday denied certiorari review in a high-profile case involving the suicide of a Reed Smith partner in 2010, an outcome that favors GlaxoSmithKline, the pharmaceutical company whose antidepressant drug was targeted as a cause of his death.

In 2017, a Chicago federal jury awarded $3 million to the widow of lawyer Stewart Dolin after finding that GlaxoSmithKline was liable for his suicide. He was taking a generic version of the company's drug Paxil.

But last August, the U.S. Court of Appeals for the Seventh Circuit overturned the damage award, ruling that the case should have been dismissed before trial because the drug company was prevented in 2007 by the U.S. Food and Drug Administration from adding suicide as a warning on the label for Paxil.